A novel generation of retroviral gene-trap vectors has been developed with the ability to induce conditional mutations in most genes expressed in mouse embryonic stem (ES) cells. The vectors rely on directional site-specific recombination systems, which can repair and re-induce the gene-trap mutations when activated in succession. After the gene-trap insertions are passaged into mice, this system enables the induction of temporally and spatially restricted mutations in somatic cells. In addition to their conditional features, the vectors create multipurpose alleles amenable to a wide range of post-insertional modifications. These vectors have been used to assemble the largest library of ES cell lines with conditional mutations in single genes, presently totalling 1724 unique genes. Due to their efficiency, the vectors are part of the core technologies to be used by EUCOMM for establishing a complete collection of conditional null mutations in mice.
INTRODUCTION
With the completion of sequencing of the human and mouse genomes, geneticists' attention has shifted towards the functional annotation of every single gene in the mammalian genome [1, 2] . Among a multitude of approaches addressing gene function, mutagenesis in the mouse is presently the most relevant for extrapolation of human genetic disease. Compared with other model organisms, the mouse offers particular advantages because its genome structure and organization are closely related to the human genome. Most importantly, the availability of mouse embryonic stem (ES) cells, which grow indefinitely in tissue culture, allows the generation of mice with defined mutations in single genes for functional analysis and studies of human disease.
Gene trapping is a high-throughput approach that is used to introduce insertional mutations across the mouse genome. It is performed with gene-trap vectors whose principal element is a gene-trapping cassette consisting of a promoterless reporter gene and/or selectable marker gene flanked by an upstream 3 0 splice site (splice acceptor; SA) and a downstream transcriptional termination sequence (polyadenylation sequence; polyA). When inserted into an intron of an expressed gene, the gene-trap cassette is transcribed from the endogenous promoter in the form of a fusion transcript in which the exon(s) upstream of the insertion site is spliced in frame to the reporter/selectable marker gene. Since transcription is terminated prematurely at the inserted polyadenylation site, the processed fusion transcript encodes a truncated and non-functional version of the cellular protein and the reporter/ selectable marker [3] . Thus, gene traps simultaneously inactivate and report the expression of the trapped genes at the insertion sites, and provide DNA tags (gene-trap sequence tag; GTST) for the rapid identification of the disrupted genes. Gene-trap approaches have been successfully used in the past by both academic and private organizations to create libraries of ES cell lines harbouring mutations in single genes [4] [5] [6] [7] . Collectively, the existing resources cover about 66% of all proteincoding genes within the mouse genome [8] .
CONDITIONAL GENE TRAPPING
Most gene-trap vectors, employed for generating currently available resources, induce only 'null' mutations so that mouse mutants generated from these libraries can report only the earliest and nonredundant developmental function of the trapped gene. Consequently, for most of the mutant strains generated from these cell lines the significance of the trapped gene for human disease remains uncertain, as most human disorders result from late onset gene dysfunction. In addition, between 20 and 30% of the genes targeted in ES cells are required for development and cause embryonic lethal phenotypes when passaged to the germline, which precludes their functional analysis in the adult [5, 9] .
To address this problem, we have developed a novel generation of gene-trap vectors [10] with the ability to induce conditional knockout alleles for most genes expressed in ES cells. We used an adaptation of a recently published site-specific recombination strategy termed FlEx (flip-excision) [11] . FlEx uses pairs of inversely oriented heterotypic recombinase target sequences (RTs) such as loxP and lox511 or frt and F3. When inserted upstream and downstream of a gene-trap cassette, Cre or FLPe recombinases invert the cassette and place two homotypic RTs near to each other in a direct orientation. Recombination between this pair of directly repeated RTs excises one of the other heterotypic RTs, thereby 'locking' the recombination product against re-inversion to the original orientation. To exploit these features, we equipped retroviral gene-trap vectors encoding a beta-galactosidase/neomycinphosphotransferase (bgeo) [12] or a CD2 antigen/neomycinphosphotransferase (Ceo) [10] with a double FlEx array consisting of frt/F3 and loxP/lox511 pairs on both sides of the gene-trap cassettes ( Figure 1A ). Mutagenic insertions of the resulting FlipRosabgeo and FlipRosaCeo into mouse genes are susceptible to both FLPe and Cre-mediated recombination, which, when delivered in succession, will induce two directional inversions. As exemplified in Figure 1B for FlipRosabgeo, this will first repair and then re-induce the gene-trap mutation.
After extensive in vitro validation studies, the FlipRosabgeo and FlipRosaCeo vectors have been used by the German Gene Trap Consortium to assemble the largest library of ES cells harbouring conditional mutations in single genes yet assembled, presently totalling 1724 genes.
MULTIPURPOSE ALLELES
The conditional gene-trap resource is freely available for immediate mutant mouse production with either germ line or somatic mutations in single genes. Moreover, by introducing heterologous recombinase target sites into the genome, the trapped ES cell lines are amenable to a large variety of post-insertional modifications by recombinase-mediated cassette exchange (RMCE) [13] . Examples include replacing the gene-trap cassettes with inducible Cre recombinase genes to expand the Cre-zoo, or point mutated minigenes to study point mutations. Further options are the induction of gain-of-function mutations or the ablation of specific cell lineages by inserting gain-of-function cassettes or toxin genes [14] , respectively.
THE EUCOMM PROJECT
Analysis of the mouse and human genomes has resulted in the identification of 28 000 genes as well as hundreds of thousands of conserved noncoding regions. Now that the human and mouse sequences are available, attention has turned to the next phase of the project, elucidation of gene function in the context of the entire organism. Gene trapping and targeting allow systematic, cost-effective and high-throughput generation of mutations in ES cells. ES cells can be easily stored, distributed and converted into mice. The value of the information gained from the analysis of mouse mutants is widely acknowledged and therefore, it was agreed by the international scientific community that the time is ripe for a worldwide concerted action to perform saturation mutagenesis of the mouse genome using gene-targeting and gene-trapping approaches [1, 2] . Such an enormous task can only be achieved by an internationally coordinated effort to systematically mutate all genes for the benefit of the scientific community. An organized systematic assault reduces redundancy, facilitates standardization, enables technical developments to be implemented globally and thereby minimizes the costs compared with uncoordinated efforts. Moreover, organized efforts enable data and The SAbgeopA cassette flanked by recombinase target sites (RTs) in a FlEx configuration is illustrated after integration into an intron of an expressed gene. Transcripts (shown as grey arrows) initiated at the endogenous promoter are spliced from the splice donor (SD) of an endogenous exon (here exon1) to the SA of the SAbgeopA cassette.Thereby the bgeo reporter gene is expressed and the endogenous transcript is captured and prematurely terminated at the cassette's pA causing a mutation. In step 1, FLPe inverts the SAbgeopA cassette onto the non-coding strand at either frt (shown) or F3 (not shown) RTs and positions frt and F3 sites between direct repeats of F3 and frt RTs, respectively. By simultaneously excising the heterotypic RTs (step 2), the cassette is locked against re-inversion as the remaining frt and F3 RTs cannot recombine. This reactivates normal splicing between the endogenous splice sites and deletes the SA geopA cassette from the mature transcript, thereby repairing the mutation. Cre-mediated inversion in steps 3 and 4 repositions the SAbgeopA cassette back onto the coding strand and reinduces the mutation. Note that the recombination products of steps 1 and 3 are unstable and thus exist only transiently.
resources to be held in repositories, which enforces standard data formats and guarantees rapid availability of resources (vectors, ES cells and mutant mice) without restrictions.
The European Conditional Mouse Mutagenesis project (EUCOMM) has been initiated to contribute to this ambitious goal. The project is built on exceptionally strong European expertise in mouse molecular genetics, genomics and bioinformatics. In close collaboration with similar programmes initiated in the US (Knockout Mouse Project, KOMP [1] ) and Canada (North American Conditional Mouse Mutagenesis Project, NorCOMM), EUCOMM will complement highthroughput gene-targeting resources with ready-touse conditional mutations in all genes throughout the mouse genome. As a first step in this direction, the publically available gene trap lines have been recently centralized on the International Gene Trap Consortium's (IGTC) web page (http://www.igtc.ac.org/) [15] .
